SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12B/A - Registration of securities [Section 12(b)]: [Amend]
SEC Accession No. 0001193125-16-647395
Filing Date
2016-07-13
Accepted
2016-07-13 17:24:59
Documents
7

Document Format Files

Seq Description Document Type Size
1 10-12B/A d26473d1012ba.htm 10-12B/A 43551
2 EX-99 d26473dex99.htm EX-99 1798832
3 GRAPHIC g26473g13b96.jpg GRAPHIC 81944
4 GRAPHIC g26473g22q54.jpg GRAPHIC 40521
5 GRAPHIC g26473g46v99.jpg GRAPHIC 62049
6 GRAPHIC g26473g71x95.jpg GRAPHIC 29769
7 GRAPHIC g26473g97t78.jpg GRAPHIC 112443
  Complete submission text file 0001193125-16-647395.txt   2292787
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-12B/A | Act: 34 | File No.: 001-37746 | Film No.: 161766194
SIC: 2834 Pharmaceutical Preparations